Breast conservation for huge-sized locally advanced breast cancer: a case report.

Abstract

A 35-year-old woman with locally advanced stage IIIB breast cancer (medullary carcinoma) 12 cm in diameter underwent neoadjuvant chemotherapy consisting of three courses of intraarterial infusion [adriamycin (ADR), mitomycin (MMC), cisplatin (CDDP), 5-fluorouracil (5FU)] and four cycles of systemic chemotherapy (ADR, epirubicin, cyclophosphamide, MMC, CDDP) for three months. The tumor markedly diminished after the first course of intraarterial infusion chemotherapy, with a 3-cm tumor remaining after the completion of preoperative administration. Pathologically complete response was noted in specimens resected following breast conservation surgery. Postoperative radiotherapy was added and adjuvant chemohormonal therapy was continued for two years. The patient is alive without recurrence and has been able to conserve the breast for the past eight years, neoadjuvant chemotherapy including intraarterial infusion enabled breast conservation treatment even for huge-sized locally advanced breast cancer.

• Authors: M Murakami, Y Kuroda, A Sano, Y Okamoto, E Yoden, S Nishimura, S Matsusue, H Takeda, Y Kobashi
• Journal: Radiation medicine (Radiat Med) 2001 May-Jun Vol. 19 Issue 3 Pg. 155-9 ISSN: 0288-2043 [Print] Japan
• PMID: 11467383 (Publication Type: Case Reports, Journal Article)

Topics

• Adult
• Breast Neoplasms (pathology, therapy)
• Carcinoma, Medullary (pathology, therapy)
• Chemotherapy, Adjuvant
• Female
• Humans
• Mastectomy, Segmental
• Neoadjuvant Therapy
• Neoplasm Staging
• Radiotherapy, Adjuvant
• Treatment Outcome